Company GeNeuro SA

Equities

GNRO

CH0308403085

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per region

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 03:00:07 2024-04-26 am EDT			5-day change	1st Jan Change
1.43 ^EUR	0.00%		0.00%	+31.19%

Mar. 20	Geneuro SA Announces Appointments of Board of Directors	CI
Feb. 02	GeNeuro: share price falls after private placement	CF

GeNeuro SA specializes in the development of safe and effective treatments against neurological disorders and autoimmune diseases such as multiple sclerosis or type 1 diabetes by neutralizing causal factors encoded by HERVs, which represent 8% of human DNA. A new frontier pioneered by GeNeuro SA since 2006 and based on research by Institut Mérieux and INSERM.

Number of employees: 19

Managers	Title	Age	Since
Jesús Martin-Garcia CEO	Chief Executive Officer	62	05-12-31
Hervé Perron FOU	Founder	66	05-12-31
Miguel Payró DFI	Director of Finance/CFO	62	15-10-31

Members of the board	Title	Age	Since
Philippe Archinard BRD	Director/Board Member	63	21-05-26
Michel Dubois BRD	Director/Board Member	81	08-07-15
Gordon Francis BRD	Director/Board Member	75	15-03-16
Giacomo di Nepi BRD	Director/Board Member	72	15-07-20
Jesús Martin-Garcia CEO	Chief Executive Officer	62	05-12-31
Hervé Perron FOU	Founder	66	05-12-31
Hedi Brahim BRD	Director/Board Member	43	20-05-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,999,028	18,367,974 ( 73.47 %)	109,605 ( 0.4384 %)	73.47 %

Name	Equities	%	Valuation
Compagnie Merieux Alliance SAS 32.82 %	9,768,695	32.82 %	15 M €
Eclosion2 SA 21.40 %	6,367,608	21.40 %	9 M €
Servier SAS 4.589 %	1,365,659	4.589 %	2 M €
Financière Arbevel SA 1.396 %	415,575	1.396 %	619 373 €
OP Asset Management Ltd. 0.5629 %	167,524	0.5629 %	249 678 €
GENEURO SA 0.4728 %	140,716	0.4728 %	209 723 €
Auriga Capital Management LLC 0.2155 %	64,138	0.2155 %	95 591 €
IFS Independent Financial Services AG 0.1177 %	35,034	0.1177 %	52 215 €
NOVACAP Asset Management SA 0.0934 %	27,809	0.0934 %	41 447 €
Vega Investment Managers SA 0.0302 %	9,000	0.0302 %	13 414 €

Name	Equities	%	Valuation
GENEURO SA 0.47%	140,716	0.47%	209,723 $

GeNeuro SA (Switzerland)

3, chemin du Pré-Fleur

1228, Plan-les-Ouates

+41 22 552 48 00

http://www.geneuro.ch

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.43 EUR

Average target price

4 EUR

Spread / Average Target

+179.72%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENEURO SA	+31.19%	45.34M
IQVIA HOLDINGS INC.	+1.12%	42.59B
MODERNA, INC.	+6.77%	40.65B
LONZA GROUP AG	+47.81%	40.57B
CELLTRION, INC.	-11.96%	26.77B
ICON PUBLIC LIMITED COMPANY	+6.01%	24.81B
ALNYLAM PHARMACEUTICALS, INC.	-24.92%	18.17B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.63%	11.7B
MEDPACE HOLDINGS, INC.	+27.16%	12.05B
UNITED THERAPEUTICS CORPORATION	+7.30%	11.1B

Other Biotechnology & Medical Research